Ram Yogev

Grants

Grants per year 2010 2012 2013 2014 2015 2050

• 4 Active
• 116 Finished

Grants per year

Search results

• Active

  Protocol D5290C00003: A Phase 2b Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MEDI8897, a Monoclonal Antibody with an Extended Half-life Against Respiratory Syncytial Virus, in Healt

  Yogev, R. (PD/PI)

  MedImmune, Inc.

  9/1/16 → 8/31/50

  Project: Research project

• Protocol R2222-RSV-1332, A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of a Human Monoclonal Antibody, REGN2222, for the Prevention of Medically Attended RSV Infection in Preterm Infants

  Yogev, R. (PD/PI)

  Regeneron Pharmaceuticals, Inc.

  10/14/15 → 8/31/50

  Project: Research project

• 1425601: Clinical Evaluation of the Alere? i RSV, Protocol Number: 1425601, PPR and Laboratory Services Agreement

  Yogev, R. (PD/PI)

  Alere Scarborough, Inc.

  1/1/15 → 8/31/50

  Project: Research project

• 1425601: Clinical Evaluation of the Alere? i RSV, Protocol Number: 1425601, PPR and Laboratory Services Agreement

  Yogev, R. (PD/PI)

  Alere Scarborough, Inc.

  1/1/15 → 8/31/50

  Project: Research project

• Finished

  NICHD-2015-TIM01: Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants with Infantile Hemangioma (IH) [PTN Opportunity #11]

  Chamlin, S. L. (PD/PI) & Yogev, R. (Co-Investigator)

  Duke University, National Institute of Child Health and Human Development

  3/14/17 → 5/28/20

  Project: Research project

• Ryan White - Part A 2017

  Yogev, R. (PD/PI)

  Chicago Department of Public Health, Health Resources and Services Administration

  3/1/17 → 2/28/18

  Project: Research project

• Protocol 1626001 - Nasopharyngeal Swab Specimen Collection for the Detection of Respiratory Syncytial Virus (RSV) (CTA SOW 5)

  Yogev, R. (PD/PI)

  Alere Scarborough, Inc.

  2/1/17 → 12/5/18

  Project: Research project

• Protocol 1616601: Evaluation of the Clinical Performance of the Modified Alere? i Strep A

  Yogev, R. (PD/PI)

  Alere Scarborough, Inc.

  1/1/17 → 2/21/18

  Project: Research project

• Protocol 1632701 - Clinical Evaluation of the Alere? BinaxNOW...

  Yogev, R. (PD/PI)

  Alere Scarborough, Inc.

  1/1/17 → 12/31/17

  Project: Research project

• Protocol 1616601: Evaluation of the Clinical Performance of the Modified Alere? i Strep A

  Yogev, R. (PD/PI)

  Alere Scarborough, Inc.

  1/1/17 → 12/31/17

  Project: Research project

• By the Alere? Reader with Viral Transport Media (VTM) (Lab Agreement)

  Yogev, R. (PD/PI)

  Alere Scarborough, Inc.

  1/1/17 → 12/31/17

  Project: Research project

• LOC-IMPAACT-Janssen, Protocol Co-Chair P1090

  Yogev, R. (PD/PI)

  Johns Hopkins University, Janssen R&D Ireland

  12/1/16 → 12/31/19

  Project: Research project

• PSTO 14: IMPAACT 2007 - Phase I Safety and Pharmacokinetics of Maraviroc in HIV-1 Exposed Infants at Risk of Acquiring HIV-1 Infection

  Yogev, R. (PD/PI)

  Johns Hopkins University, ViiV Healthcare

  10/11/16 → 12/31/19

  Project: Research project

• Protocol # 1612601: Evaluation of the Clinical Performance of the Modified Alere i Influenza A&B Test

  Yogev, R. (PD/PI)

  Alere Scarborough, Inc.

  10/1/16 → 9/30/21

  Project: Research project

• NICHD-2015-AED01: Pharmacokinetics of Anti-epileptic Drugs in Obese Children - Phase I

  Yogev, R. (PD/PI)

  Duke University, National Institute of Child Health and Human Development

  8/1/16 → 3/28/20

  Project: Research project

• Ryan White - Part A 2016: Carryover

  Yogev, R. (PD/PI)

  Chicago Department of Public Health, Health Resources and Services Administration

  3/1/16 → 2/28/17

  Project: Research project

• Ryan White - Part A 2016

  Yogev, R. (PD/PI)

  Chicago Department of Public Health, Health Resources and Services Administration

  3/1/16 → 2/28/17

  Project: Research project

• Protocol DAL-PK-02: Pharmacokinetics of a Single-Dose of Dalbavancin in Preterm Neonates to Infants Ages 3 Months with Suspected or Confirmed Bacterial Infection

  Yogev, R. (PD/PI)

  Allergan Sales, LLC

  2/14/16 → 5/10/18

  Project: Research project

• Protocol 1518101: Clinical Evaluation of the Alere BinaxNOW Influenza A&B Card Assay and Alere Reader (Laboratory Agreement)

  Yogev, R. (PD/PI)

  Alere Scarborough, Inc.

  11/1/15 → 9/28/18

  Project: Research project

• NICHD R01HD076676: PBPK - R01, Pharmacokinetics of Clindamycin and Trimethoprim-Sulfamethoxazole in Infants and Children (Phase 1 Trial)

  Yogev, R. (PD/PI)

  Duke University, National Institute of Child Health and Human Development

  11/1/15 → 6/30/18

  Project: Research project

• Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC): PH200 AMP

  Yogev, R. (PD/PI)

  Harvard University, National Institute of Child Health and Human Development

  9/9/15 → 7/31/20

  Project: Research project

• Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC): PH200 AMP

  Yogev, R. (PD/PI), Chadwick, E. (Co-Investigator), Malee, K. M. (Co-Investigator) & Muller, W. J. (Co-Investigator)

  Harvard University, National Institute of Child Health and Human Development

  9/9/15 → 7/31/21

  Project: Research project

• Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC): PH200 AMP

  Yogev, R. (PD/PI), Chadwick, E. (Co-Investigator), Malee, K. M. (Co-Investigator) & Muller, W. J. (Co-Investigator)

  Harvard University, National Institute of Child Health and Human Development

  9/9/15 → 7/31/20

  Project: Research project

• Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC): PH200 AMP

  Yogev, R. (PD/PI), Chadwick, E. (Co-Investigator), Malee, K. M. (Co-Investigator) & Muller, W. J. (Co-Investigator)

  Harvard University, National Institute of Child Health and Human Development

  9/9/15 → 7/31/20

  Project: Research project

• Pediatric HIV/AIDS Cohort Study (PHACS) Data and Operations Center (DOC): PH200 AMP

  Yogev, R. (PD/PI), Chadwick, E. (Co-Investigator), Malee, K. M. (Co-Investigator) & Muller, W. J. (Co-Investigator)

  Harvard University, National Institute of Child Health and Human Development

  9/9/15 → 7/31/20

  Project: Research project